top of page

Our team


Emma Medin

CEO, Partner, Senior Advisor
Market Access & HTA

Emma holds 18 years of life science experience whereof 16 from leading market access, reimbursement, outcomes research, health economics and real-world evidence registry studies in the academic and consultancy setting.


She established and managed for 12 years the Nordic Access consulting team of Heron Evidence Development which later became part of the international CRO firm Parexel. Most recently, Emma was also assigned the global Access consulting operations and development lead role, where she was driving professional development programs, operational processes and business-growth strategies for Parexel. Emma is affiliated to the Karolinska Institutet and prior to consulting she was working in clinical practice, as a physician.


Emma is an expert in market access strategy development, reimbursement dossier development and submission in Sweden, Norway, Denmark and Finland and holds specific TA expertise in immuno-oncology, oncology, neurology, orphan diseases, cell and gene therapy. She holds and MD from Karolinska Institutet and a MSc in Economics from Stockholm University. Emma is also a PhD candidate at the Unit for Health Economics and Policy at the Department of LIME at Karolinska Institutet LIME Dept.

bottom of page